Hyper IgM Foundation Offers $25K in Seed Grant Funding
The Hyper IgM Foundation is proud to announce the availability of $25,000 in seed grant funding for researchers interested in the advancement of a cure for Hyper IgM Syndrome and primary immunodeficiency disorders. The intent of this funding is to accelerate scientific work focused on improving the treatment, quality of life, and long-term outlook for patients with Hyper IgM. Special consideration will be given to well-defined projects focused on gene therapy/editing for CD40 Ligand Deficiency as well as hematopoietic stem cell transplantation for CD40 Ligand Deficiency.
During the 2019 calendar year, the Hyper IgM Foundation will be awarding one-time grants of up to $25,000 to worthy recipients. Grant applications for 2019 grants have a submission deadline of June 30th, 2019.